aTyr Pharma, Inc.ATYRNASDAQ

Revenue (LTM)

$190000

-19.1% YoY

Net Income (LTM)

$-74M

-15.8% YoY

Free Cash Flow

$-62M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	10	0↓96.6%	0↓33.4%	0↓19.1%
Gross Profit	-1	9↑766.5%	0↓95.9%	0↓33.4%	-1↓680.0%
Operating Income	-34	-46↓36.4%	-55↓18.3%	-68↓23.7%	-78↓14.3%
Net Income	-34	-45↓34.3%	-50↓11.1%	-64↓27.1%	-74↓15.8%
EBITDA	-32	-45↓37.7%	-52↓16.7%	-66↓27.2%	-76↓14.6%
EPS Diluted	-1.77	-1.60↑9.6%	-0.94↑41.3%	-0.86↑8.5%	-0.80↑7.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	2	10↑327.3%	23↑125.9%	11↓51.0%	11↓2.8%
Total Current Assets	114	81↓28.8%	103↑27.4%	82↓20.4%	80↓2.1%
Total Assets	116	96↓17.1%	121↑26.0%	97↓19.7%	94↓2.8%
Total Current Liabilities	6	14↑130.5%	16↑18.4%	15↓8.8%	15↑1.2%
Total Liabilities	6	25↑282.2%	30↑23.2%	27↓10.6%	27↓0.5%
Total Equity	109	71↓34.6%	91↑26.9%	70↓22.8%	67↓3.6%
Total Debt	1	12↑737.0%	15↑30.9%	13↓12.0%	12↓9.4%
Net Debt	-1	2↑262.1%	-7↓579.7%	2↑129.9%	1↓42.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-33	-42↓26.6%	-33↑20.7%	-69↓108.1%	-62↑10.3%
Capital Expenditure	-0	-2↓754.7%	-4↓156.9%	-0↑98.5%	-0↓18.5%
Free Cash Flow	-33	-44↓30.8%	-37↑14.0%	-69↓84.8%	-62↑10.3%
Stock-Based Comp	2	2↑33.5%	3↑20.7%	3↑15.0%	5↑67.2%
Net Change in Cash	-15	11↑174.0%	13↑19.2%	-12↓193.3%	-1↑91.4%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance